US20120004497A1 - Physiological Demand Responsive Control System - Google Patents

Physiological Demand Responsive Control System Download PDF

Info

Publication number
US20120004497A1
US20120004497A1 US13/172,748 US201113172748A US2012004497A1 US 20120004497 A1 US20120004497 A1 US 20120004497A1 US 201113172748 A US201113172748 A US 201113172748A US 2012004497 A1 US2012004497 A1 US 2012004497A1
Authority
US
United States
Prior art keywords
pump
controller
speed
physiological
detected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/172,748
Inventor
Peter Joseph Ayre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thoratec LLC
Original Assignee
Thoratec LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thoratec LLC filed Critical Thoratec LLC
Priority to US13/172,748 priority Critical patent/US20120004497A1/en
Publication of US20120004497A1 publication Critical patent/US20120004497A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/80Constructional details other than related to driving
    • A61M60/802Constructional details other than related to driving of non-positive displacement blood pumps
    • A61M60/818Bearings
    • A61M60/824Hydrodynamic or fluid film bearings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10Location thereof with respect to the patient's body
    • A61M60/122Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/165Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
    • A61M60/178Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20Type thereof
    • A61M60/205Non-positive displacement blood pumps
    • A61M60/216Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
    • A61M60/226Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly radial components
    • A61M60/232Centrifugal pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50Details relating to control
    • A61M60/508Electronic control means, e.g. for feedback regulation
    • A61M60/515Regulation using real-time patient data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50Details relating to control
    • A61M60/508Electronic control means, e.g. for feedback regulation
    • A61M60/515Regulation using real-time patient data
    • A61M60/523Regulation using real-time patient data using blood flow data, e.g. from blood flow transducers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50Details relating to control
    • A61M60/508Electronic control means, e.g. for feedback regulation
    • A61M60/538Regulation using real-time blood pump operational parameter data, e.g. motor current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50Details relating to control
    • A61M60/585User interfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3303Using a biosensor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3334Measuring or controlling the flow rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/04Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • A61M2230/06Heartbeat rate only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/63Motion, e.g. physical activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10Location thereof with respect to the patient's body
    • A61M60/122Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/126Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
    • A61M60/148Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50Details relating to control
    • A61M60/508Electronic control means, e.g. for feedback regulation
    • A61M60/562Electronic control means, e.g. for feedback regulation for making blood flow pulsatile in blood pumps that do not intrinsically create pulsatile flow

Definitions

  • the present invention relates to a demand responsive physiological control system and, more particularly, to such a system particularly suited for use with blood pumps and, even more particularly, those used to assist heart function such as, for example, ventricular assist devices.
  • the heart of a mammal may cause the amount of blood that is to be circulated through the body to change not just for what might be termed obvious reasons such as an increase in physical exertion by a person, but may also occur for example, as a result of anticipation of exertion.
  • the triggers which can cause changes in heart rate and pumped blood volume may derive from the nervous system directly or may derive from the action of hormones or other chemical releases within the body.
  • control mechanisms simply set the ventricular assist device to pump at a constant volume per unit time, adjusted at the time of initial installation to best suit the patient in whom the device has been installed.
  • a demand responsive physiological control system for use with a rotary blood pump; said system including a pump controller which is capable of controlling pump speed of said pump; said system further including a physiological controller, and wherein said physiological controller is adapted to analyze input data relating to physiological condition of a user of said pump; and wherein said physiological controller determines appropriate pumping speed and sends a speed control signal to said pump controller to adjust pump speed; said system further including a physiological state detector which provides said input data indicative of at least one physiological state of said user, in use, to said physiological controller.
  • the physiological state detector includes an accelerometer to sense motion of the user, when in use.
  • the accelerometer senses motion in at least one axis.
  • the accelerometer senses motion in three orthogonal axes.
  • said system includes a pump monitor that detects information relating to voltage and current of the pump and delivers this information to said physiological controller.
  • Preferably said pump monitor detects an instantaneous pump impeller speed of the rotary blood pump through measurements.
  • Preferably said pump monitor detects non-invasively.
  • Preferably said physiological controller uses said information received from the pump monitor to derive mathematically an appropriate pump speed.
  • said physiological controller assesses flow dynamics and an average flow estimate, developed from speed and input power supplied to the pump by the pump controller.
  • said physiological controller mathematically determines a pumping state and if a deleterious state is determined the speed control signal is changed accordingly.
  • a physiological detector includes a means of detecting and quantifying a heart rate of the user, when in use.
  • said physiological detector includes a means of non-invasively detecting and quantifying a heart rate of the user, in use.
  • Preferably said physiological controller can determine a heart rate of the user by sensing speed of the pump.
  • Preferably said physiological controller can determine a heart rate of the user using power inputted to the pump.
  • said pump is internally implantable within the user.
  • the pump is a ventricle assist device.
  • the pump has a hydrodynamic bearing that produces a relatively flat pump head versus pump flow curve.
  • said physiological controller is capable of manual manipulation by the user.
  • Preferably said manual manipulation is within adjustable predefined limits.
  • said physiological controller is adapted for communication with a computer and wherein the physiological controller is adapted for manipulation by a software user interface.
  • said physiological controller includes an alarm.
  • a process for using physiological demand data to optimize pump speed of a rotary blood pump comprising of the following steps: a heart rate of the user is non-invasively determined; a level of physiological exertion of the user is determined through non invasive means; an instantaneous pump speed and input power is used to calculate instantaneous blood flow rate; a pumping state is mathematically determined; the heart rate, pumping state and level of physical exertion are compared to the blood flow rate; and the pumping speed of the rotary blood pump is changed to appropriately supply the user with the correct blood flow rate.
  • a pump control system for a pump for use in a heart assist device; said system comprising data processing means which receives body motion information and heart rate information thereby to derive a speed control signal for impeller speed of an impeller of said pump.
  • said body motion information is derived from an accelerometer.
  • said accelerometer senses motion in a single axis.
  • said accelerometer senses motion in three orthogonal axes.
  • said heart rate information is derived from a non-invasive sensor.
  • said heart rate information is derived from voltage and current applied to an electric motor driving said impeller.
  • a method of control of pump speed of a blood pump comprising establishing a base set point speed; said method further comprising establishing one or more criteria which, if satisfied, cause establishment of at least a second set point speed; said second set point speed higher than that of said base set point speed.
  • FIG. 1 is a diagram of a ventricular assist device installation within a human body suitable for control by embodiments of the present invention
  • FIG. 2 is a block diagram of a physiological demand responsive of control system applicable to the system of FIG. 1 in accordance with a first preferred embodiment of the present invention
  • FIG. 3 illustrates graphically the behavior of the control system of FIG. 2 under specified physiological conditions
  • FIG. 4 is a graph of accelerometer behavior utilized as a basis for an input to the control algorithm of the first preferred embodiment
  • FIG. 5 is a block diagram of a control system in accordance with a second preferred embodiment of the present invention.
  • FIG. 6 is a block diagram of a pumping state detection module for use with the second embodiment
  • FIG. 7 is a flowchart for determining pump drive set point for the arrangement of the second embodiment
  • FIG. 8 illustrates graphically an HQ curve for a preferred pump type particularly suited for use with the control system of FIG. 2 or FIG. 5 ;
  • FIG. 9 is a diagram of a preferred embodiment of the present invention wherein said diagram shows preferred inputs and outputs.
  • FIG. 1 With initial reference to FIG. 1 there is illustrated in diagrammatic form a blood pump 10 installed within a human body 11 and arranged to function as a left ventricular assist device.
  • the pump 10 is arranged to operate in parallel with blood flow passing through left ventricle 12 . This is effected by inserting an inlet cannula 13 into left ventricle 12 and directing blood flow through the inlet cannula into an inlet of blood pump 10 .
  • Blood pump 10 in operational mode, pumps the blood thus received into aorta 14 via outlet cannula 15 , as illustrated in FIG. 1 .
  • the blood pump 10 can take a number of forms and rely on a number of different pumping and drive technologies.
  • the pump technology can be based on axial or centrifugal rotary pump arrangements or on positive displacement technologies.
  • preferred pumping technologies for the control system to be described below include rotary pump technologies which rely on an impeller supported for rotation within a casing and which causes blood to be urged between an inlet and outlet of the casing as the impeller rotates therein.
  • a centrifugal form of pump can be utilized with the control system with the characteristics of the pump tailored to compliment or otherwise work particularly advantageously with the control system according to various embodiments of the present invention.
  • the pump 10 is driven by an electrical power source, in this instance a battery pack 16 mounted externally of the body. Electrical power from the battery pack 16 is controlled by a controller unit 17 , also mounted externally of the body. In addition to communicating electrical power to the pump 10 the controller 17 can also communicate with an external programming source, in this case a personal computer 18 for the purposes of initial setup and ongoing periodic monitoring and recalibration of the pump and controller as customized for a specific patient.
  • an electrical power source in this instance a battery pack 16 mounted externally of the body.
  • the controller 17 can also communicate with an external programming source, in this case a personal computer 18 for the purposes of initial setup and ongoing periodic monitoring and recalibration of the pump and controller as customized for a specific patient.
  • Embodiments of a control system suited for use, although not exclusively, with the controller 17 of the arrangement described above and with reference to FIG. 1 will now be described.
  • non-invasive is applied to the derivation of various physiological parameters of body 11 (including blood flow rates and the like) by means which do not require sensors to be placed (invasively) within the body.
  • IRBP implantable rotary blood pump
  • LVAD left ventricular assist device
  • V voltage applied to pump motor
  • TVC total ventricular collapse
  • PVC partial ventricular collapse
  • the aim is to provide a pump controller which utilizes a control algorithm which takes as its two primary inputs for decision making firstly an indication of the degree of movement of body 11 per unit time as a coarse measure of exertion and hence pumping load required of the heart and particularly left ventricle 12 and secondly an indication of heart rate derived, in this instance, non-invasively by monitoring of electrical parameters driving pump 10 .
  • the block diagram shown in FIG. 2 shows the signals that are derived (non-invasively) from pump motor power and speed.
  • the strategy is to measure speed instantaneously every revolution of the impeller as a digital signal from the motor commutation electronics.
  • the haemo-dynamic controller electronics measure the frequency of this signal which is proportional to impeller speed.
  • speed is an advantage since it is a digital signal, which in practice has been found to be an inherently less electrically noisy signal than that derived from measuring motor current or power.
  • rms root mean square
  • Each pulse from the commutation controller represents 1 ⁇ 6 th of a rotation of the impeller and is time stamped relative to a reference time base. Therefore the angular velocity ⁇ of the impeller for each 60° of rotation is described by equation 1.
  • Tn+1 ⁇ Tn is the time difference between pulses (interrupts) in seconds.
  • ⁇ (t) is converted to speed N(t) in rpm by multiplying by 60/2II as-in equation 2
  • N ⁇ ( t ) 60 ⁇ ⁇ ⁇ ( t ) 2 ⁇ ⁇ equation ⁇ ⁇ 2
  • Rms speed is calculated in equation 3 from a moving window of samples of N(t), the sample rate dependent on impeller speed. Each instantaneous speed sample is time stamped at t 1 to t n .
  • Nrms ⁇ ( t ) ⁇ o n ⁇ [ N ⁇ ( t ) ] 2 n equation ⁇ ⁇ 3
  • Vm(t) and Im(t) are the “instantaneous” motor coil voltage and summed phase current respectively, sampled.
  • a moving window of samples of Pin(t) is used to calculate P rms (t) using equation 5.
  • control strategy is similar to that described with respect to the first embodiment but, in addition, includes as a further control input derived from non-invasively determined parameters the “pumping state” of pump 10 .
  • This feature provides a safety-override mechanism as illustrated in the flowchart of FIG. 7 thereby to ensure that the basic control strategy described with reference to the first embodiment is less likely to put the patient at risk.
  • FIG. 5 is a block diagram of the control arrangement wherein, in addition to the input variables described with reference to example 1 there is a “physical motion” input which can be derived from an accelerometer associated with a patient.
  • the accelerometer can be a single axis accelerometer. In alternative forms multiple axes of accelerometer sensing can be utilized.
  • Physiologically critical pumping state detection methods are used based on the non-invasive system observers pump speed and electrical input power. Activity level is detected using heart rate (detected from pump impeller instantaneous speed) and motion by using an accelerometer although other measuring devices may be used without departing from the scope of the present invention. These non-invasive observers are utilized as inputs to a control algorithm for a rotary blood pump to seek to ensure that pump output is better adapted to patient rest and exercise states.
  • the state PVC is indicated by a variation in symmetry of the instantaneous speed waveform given a level of pulsatility. Given that normal flow rates can still be observed during this state and that flow pulsatility is large, the only parameter distinguishing this state from the VE state is the flow symmetry.
  • State VE may be identified non invasively by pump flow rate being larger than 1 L/min and peak to peak instantaneous voltage (flow) being greater than a threshold value and the flow symmetry being greater than that for the PVC state.
  • the PR state may be indicated when the pump flow falls below the lower flow limits Qmin which is set to be 1 L/min. This level of Qmin is set at 1 L/min although not “0 L/min” may be was considered a safe limit to be classed as retrograde flow.
  • Estimated pump flow Q est is derived from N rms (t) and PWR rms (t).
  • the RMS of instantaneous pump speed N rms (t) and power PWR rms t) are derived from instantaneous speed N(t) and power PWR(t).
  • the haemo-dynamic controller electronics measure the frequency of the speed signal, which is proportional to impeller speed. Using speed rather than power as an observer for dynamic changes is an advantage since it is a digital signal, substantially free from electrical noise which may contribute to error.
  • Equation 6 is used to model low and normal flow rate through the pump based on RMS impeller speed and electrical input power.
  • a flow Index, Q p Index, shown in equation 7 is developed to distinguish between low flow rates and normal flow rates. by incorporating Q est . If Q p Index>50 this corresponds in this example to a flow rate greater than 1 L/min. A Q p Index ⁇ 50 means that flow is less than 1 L/min or “low flow”
  • States TVC and AC produce near non pulsatile pump flow. The difference between these states is that state AC occurs when the circulation is supported and state TVC when it is not. These states can be differentiated by comparing Q est Index. States PVC, VE and PR produces pulsatile flow. States PVC and VE produce flow which supports the circulation whereas state PR compromises the circulation due to back flow through the pump. It has been shown that instantaneous speed amplitude is proportional to pump flow amplitude.
  • the flow pulsatility index Q p.p Index (equation 9) is developed based on instantaneous speed amplitude N p-p (n) (equation 8) which is equal to the difference between the maximum and the minimum instantaneous impeller speed N max (n) and N min (n) for the n th cardiac cycle.
  • the index outputs a value greater than 50 for pulsatile flow and less than 50 for non pulsatile flow.
  • N p-p ( n ) N max ( n ) ⁇ N min ( n ) equation 8
  • States PVC and VE both produce flow rates which support the circulation and a degree of pulsatility. Differentiating between states can be achieved by considering the symmetry of the flow wave form which is reflected in instantaneous speed.
  • the symmetry of flow rate is an inversion of the instantaneous speed signal.
  • the flow symmetry index Q sym Index (equation 11) is developed by using the inverted speed waveform symmetry defined by equation 10 with the symmetry threshold Q sym MAX set at 0. The index is set so that if the flow symmetry falls below 0.3 (speed symmetry rises above 0.7) its output is less than 50.
  • N sym ( N nrms ⁇ ( n ) - N min ⁇ ( n ) N p - p ⁇ ( n ) equation ⁇ ⁇ 10
  • Q sym ⁇ Index 50 ⁇ Q sym ⁇ max .
  • the block diagram shown in FIG. 5 shows the module that combines the detection methods discussed above derived from instantaneous power and speed.
  • the current state is determined by the logic table shown in FIG. 6 where flow, flow pulsatility and symmetry are used to decide the present pumping state.
  • the heart rate is calculated by using the array of speed samples.
  • the frequency of speed is calculated by using the derivative of speed and detecting the time of the speed maxima and minima.
  • the derivative of speed is defined in equation 12.
  • HR is then calculated by time stamping the maxima and minima of the speed signal given by HRa and HRb in is equations 13 and 14. The average is then computed and used as HR using equation 15. Speed maxima are detected by dN(t n )/dt changing from a positive to a negative value. Speed minima are detected by dN(t n )/dt changing from a negative to a positive value. T max(n) , t max(n-1) , t min(n) , t min(n-1) are the time stamps for the maximum and minimum values of instantaneous speed.
  • An accelerometer is mounted in the controller electronics and used to detect physical motion.
  • the accelerometer output is amplified by a differential amplifier and integrated to provide a signal level indicating continuous physical motion.
  • a preferred embodiment of the present invention of the physiological demand responsive controller is suited for used with implantable third generation LVASs. Also, a further embodiment of the present invention is designed to cooperate with a VentrassistTM left ventricle assist system (LVAS).
  • LVAS VentrassistTM left ventricle assist system
  • One of the preferred embodiments may automatically adjust the pumping speed of an implanted third generation blood pump to an optimal level for the varying physiological needs of the implanted patient.
  • the preferred embodiment may achieve this by periodically iteratively changing the speed setpoint of the pump.
  • the control system detects increased physiological demand by the patient (e.g. by physical exertion) the controller will increase the pumping speed accordingly.
  • the pumping state of the patient's heart and physiological demand of the patient will be computed by the control system. in real time as functions of the pump's motor power and speed setpoint of the pump.
  • the physiological demand of the patient may also be detected by the use of a three axis accelerometer.
  • This accelerometer may be able to detect the instantaneous motion of the patient. Preferably, this instantaneous motion may also be indicative of the relative motion of the patient.
  • the numerically represented version of the physiological demand state may then be inputted into the control system for a pumping device or medical device.
  • the pumping speed of the implantable blood pump may then be altered in respect of the predetermined range for physiological demand for a particular patient.
  • the predetermined ranges of pumping speeds will be set by a specialist doctor at the time of implantation of the blood pump. Additionally, it may be preferable to allow doctors to amend the predetermined range as they see fit.
  • control system may include a specialized algorithm.
  • This algorithm may include a mathematical model of ideal pumping speed of an implantable blood pump for suitable physiological conditions of the patient.
  • This algorithm may receive input or data included within three broad areas of data. These areas of data may include pump power, instantaneous pump speed and physical motion.
  • the algorithm within the controller system may use these areas of data to predict certain patient data. This patient data may include blood flow rate, heart rate, flow profile, pulsatility and physiological demand.
  • the algorithm will then output the preferred pump speed and the remainder of the controller system will use this information to set a speed setpoint for the blood pump.
  • an embodiment of the present invention will be such that iterative changes will be able to be made in timely manner.
  • a preferred physiological demand responsive controller system may be adapted for use with a radial off flow type centrifugal blood pump.
  • the system is particularly suited for use with pumps which exhibit a relatively flat HQ curve as described with reference to FIG. 8 .
  • pumps of the radial off flow type as, for example, described in International Patent Application PCT/AU98/00725 can exhibit this relatively flat characteristic.
  • the description of PCT/AU98/00725 is incorporated herein by cross-reference.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Anesthesiology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Human Computer Interaction (AREA)
  • External Artificial Organs (AREA)

Abstract

A demand responsive physiological control system for use with a rotary blood pump; said system including a pump controller which is capable of controlling pump speed of said pump; said system further including a physiological controller, and wherein said physiological controller is adapted to analyze input data relating to physiological condition of a user of said pump; and wherein said physiological controller determines appropriate pumping speed and sends a speed control signal to said pump controller to adjust pump speed; said system further including a physiological state detector which provides said input data indicative of at least one physiological state of said user, in use, to said physiological controller.

Description

    PRIORITY CLAIM
  • This application is divisional of U.S. application Ser. No. 10/529,657 filed Nov. 28, 2006, which is a national stage application of PCT/AU03/01281 filed Sep. 30, 2003, which claims priority to AU 2002951685 filed Sep. 30, 2002.
  • The present invention relates to a demand responsive physiological control system and, more particularly, to such a system particularly suited for use with blood pumps and, even more particularly, those used to assist heart function such as, for example, ventricular assist devices.
  • BACKGROUND
  • With particular reference to physiological control systems in mammals and more particularly those of the human body it has been noted that the control systems which the body itself uses to control various organs are complex.
  • For example, the heart of a mammal may cause the amount of blood that is to be circulated through the body to change not just for what might be termed obvious reasons such as an increase in physical exertion by a person, but may also occur for example, as a result of anticipation of exertion. Furthermore the triggers which can cause changes in heart rate and pumped blood volume may derive from the nervous system directly or may derive from the action of hormones or other chemical releases within the body.
  • It follows, where mechanical aids are introduced into the body to assist the body's functions such as, for example, implantable rotary blood pumps used as ventricular assist devices that simplistic control mechanisms for these mechanical aids cannot hope to anticipate or mimic the commands which the body may pass to the heart.
  • For example, in early applications of ventricular assist devices the control mechanisms simply set the ventricular assist device to pump at a constant volume per unit time, adjusted at the time of initial installation to best suit the patient in whom the device has been installed.
  • Such systems use pump speed as the controlled variable. Unfortunately, a set pump speed bears no relation to actual physiological demand.
  • It is an object of the present invention to address or ameliorate one or more of the above mentioned disadvantages.
  • BRIEF DESCRIPTION OF INVENTION
  • Accordingly, in one broad form the invention there is provided a demand responsive physiological control system for use with a rotary blood pump; said system including a pump controller which is capable of controlling pump speed of said pump; said system further including a physiological controller, and wherein said physiological controller is adapted to analyze input data relating to physiological condition of a user of said pump; and wherein said physiological controller determines appropriate pumping speed and sends a speed control signal to said pump controller to adjust pump speed; said system further including a physiological state detector which provides said input data indicative of at least one physiological state of said user, in use, to said physiological controller.
  • Preferably said the physiological state detector includes an accelerometer to sense motion of the user, when in use.
  • Preferably said the accelerometer senses motion in at least one axis.
  • Preferably said the accelerometer senses motion in three orthogonal axes.
  • Preferably said system includes a pump monitor that detects information relating to voltage and current of the pump and delivers this information to said physiological controller.
  • Preferably said pump monitor detects an instantaneous pump impeller speed of the rotary blood pump through measurements.
  • Preferably said pump monitor detects non-invasively.
  • Preferably said physiological controller uses said information received from the pump monitor to derive mathematically an appropriate pump speed.
  • Preferably said physiological controller assesses flow dynamics and an average flow estimate, developed from speed and input power supplied to the pump by the pump controller.
  • Preferably said physiological controller mathematically determines a pumping state and if a deleterious state is determined the speed control signal is changed accordingly.
  • In a further broad form of the invention there is provided a physiological detector includes a means of detecting and quantifying a heart rate of the user, when in use.
  • Preferably said physiological detector includes a means of non-invasively detecting and quantifying a heart rate of the user, in use.
  • Preferably said physiological controller can determine a heart rate of the user by sensing speed of the pump.
  • Preferably said physiological controller can determine a heart rate of the user using power inputted to the pump.
  • Preferably said pump is internally implantable within the user.
  • Preferably said the pump is a ventricle assist device.
  • Preferably said the pump has a hydrodynamic bearing that produces a relatively flat pump head versus pump flow curve.
  • Preferably said physiological controller is capable of manual manipulation by the user.
  • Preferably said manual manipulation is within adjustable predefined limits.
  • Preferably said physiological controller is adapted for communication with a computer and wherein the physiological controller is adapted for manipulation by a software user interface.
  • Preferably said physiological controller includes an alarm.
  • In a further broad form of the invention there is provided a process for using physiological demand data to optimize pump speed of a rotary blood pump wherein the process comprises of the following steps: a heart rate of the user is non-invasively determined; a level of physiological exertion of the user is determined through non invasive means; an instantaneous pump speed and input power is used to calculate instantaneous blood flow rate; a pumping state is mathematically determined; the heart rate, pumping state and level of physical exertion are compared to the blood flow rate; and the pumping speed of the rotary blood pump is changed to appropriately supply the user with the correct blood flow rate.
  • In yet a further broad form of the invention there is provided a pump control system for a pump for use in a heart assist device; said system comprising data processing means which receives body motion information and heart rate information thereby to derive a speed control signal for impeller speed of an impeller of said pump.
  • Preferably said body motion information is derived from an accelerometer.
  • Preferably said accelerometer senses motion in a single axis.
  • Preferably said accelerometer senses motion in three orthogonal axes.
  • Preferably said heart rate information is derived from a non-invasive sensor.
  • Preferably said heart rate information is derived from voltage and current applied to an electric motor driving said impeller.
  • In yet a further broad form of the invention there is provided a method of control of pump speed of a blood pump; said method comprising establishing a base set point speed; said method further comprising establishing one or more criteria which, if satisfied, cause establishment of at least a second set point speed; said second set point speed higher than that of said base set point speed.
  • BRIEF DESCRIPTION OF DRAWINGS
  • Embodiments of the present invention will now be described with reference to the accompanying drawings wherein:
  • FIG. 1 is a diagram of a ventricular assist device installation within a human body suitable for control by embodiments of the present invention;
  • FIG. 2 is a block diagram of a physiological demand responsive of control system applicable to the system of FIG. 1 in accordance with a first preferred embodiment of the present invention;
  • FIG. 3 illustrates graphically the behavior of the control system of FIG. 2 under specified physiological conditions;
  • FIG. 4 is a graph of accelerometer behavior utilized as a basis for an input to the control algorithm of the first preferred embodiment;
  • FIG. 5 is a block diagram of a control system in accordance with a second preferred embodiment of the present invention;
  • FIG. 6 is a block diagram of a pumping state detection module for use with the second embodiment;
  • FIG. 7 is a flowchart for determining pump drive set point for the arrangement of the second embodiment;
  • FIG. 8 illustrates graphically an HQ curve for a preferred pump type particularly suited for use with the control system of FIG. 2 or FIG. 5; and
  • FIG. 9 is a diagram of a preferred embodiment of the present invention wherein said diagram shows preferred inputs and outputs.
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • With initial reference to FIG. 1 there is illustrated in diagrammatic form a blood pump 10 installed within a human body 11 and arranged to function as a left ventricular assist device. The pump 10 is arranged to operate in parallel with blood flow passing through left ventricle 12. This is effected by inserting an inlet cannula 13 into left ventricle 12 and directing blood flow through the inlet cannula into an inlet of blood pump 10. Blood pump 10, in operational mode, pumps the blood thus received into aorta 14 via outlet cannula 15, as illustrated in FIG. 1.
  • The blood pump 10 can take a number of forms and rely on a number of different pumping and drive technologies. Broadly, the pump technology can be based on axial or centrifugal rotary pump arrangements or on positive displacement technologies.
  • In particular, although not limiting forms, preferred pumping technologies for the control system to be described below include rotary pump technologies which rely on an impeller supported for rotation within a casing and which causes blood to be urged between an inlet and outlet of the casing as the impeller rotates therein. In more particular preferred forms a centrifugal form of pump can be utilized with the control system with the characteristics of the pump tailored to compliment or otherwise work particularly advantageously with the control system according to various embodiments of the present invention.
  • Typically the pump 10 is driven by an electrical power source, in this instance a battery pack 16 mounted externally of the body. Electrical power from the battery pack 16 is controlled by a controller unit 17, also mounted externally of the body. In addition to communicating electrical power to the pump 10 the controller 17 can also communicate with an external programming source, in this case a personal computer 18 for the purposes of initial setup and ongoing periodic monitoring and recalibration of the pump and controller as customized for a specific patient.
  • Embodiments of a control system suited for use, although not exclusively, with the controller 17 of the arrangement described above and with reference to FIG. 1 will now be described.
  • DEFINITIONS
  • In the description which follows, the following definitions of various terms as referenced therein are to be utilized:
  • “non-invasive” is applied to the derivation of various physiological parameters of body 11 (including blood flow rates and the like) by means which do not require sensors to be placed (invasively) within the body.
  • “IRBP”—implantable rotary blood pump.
  • “LVAD”—left ventricular assist device.
  • “LVP”—left ventricular pressure.
  • “RMS” or “rms”—route mean square.
  • “V”—volts applied to pump motor.
  • “I”—current consumed by pump motor.
  • “SVR”—Systemic Vascular Resistance
  • “VR”—Venous Resistance
  • “H”—pump head pressure.
  • “N”—pump impeller rotation speed.
  • “Q”—flow rate of blood through pump.
  • “P” or “PWR”—pump power consumption.
  • “ω”—angular velocity of impeller.
  • “t”—time.
  • Pumping States
  • “TVC”—total ventricular collapse.
  • “PR”—pump regurgitation.
  • “PVC”—partial ventricular collapse.
  • “AC”—aortic valve closed.
  • “VE”—ventricle ejecting
  • First Embodiment
  • With initial reference to FIGS. 1-4 a first preferred embodiment of a control algorithm and control system is described below and by way of example.
  • In this embodiment the aim is to provide a pump controller which utilizes a control algorithm which takes as its two primary inputs for decision making firstly an indication of the degree of movement of body 11 per unit time as a coarse measure of exertion and hence pumping load required of the heart and particularly left ventricle 12 and secondly an indication of heart rate derived, in this instance, non-invasively by monitoring of electrical parameters driving pump 10.
  • The system described with reference to FIGS. 1-4 exhibits the following characteristics:
  • 1. Allowing motor speed to vary and deriving control information from those time varying signals; and
  • 2. Concept of using control of power input or speed to the motor/pump.
  • The block diagram shown in FIG. 2 shows the signals that are derived (non-invasively) from pump motor power and speed. To detect these conditions the strategy is to measure speed instantaneously every revolution of the impeller as a digital signal from the motor commutation electronics. The haemo-dynamic controller electronics measure the frequency of this signal which is proportional to impeller speed. Using speed is an advantage since it is a digital signal, which in practice has been found to be an inherently less electrically noisy signal than that derived from measuring motor current or power. Both instantaneous speed and root mean square (rms) of speed are calculated. Also instantaneous pump input power and rms of pump input power are calculated.
  • Many researchers only discuss constant speed or speed set point. However the present control strategy allows impeller speed and pump input power to be freely modulated by ventricular contractions and uses the resulting dynamic information as feedback to the control system. The characteristics of centrifugal IRBPs mean that impeller speed is more sensitive to hydraulic load variations than for axial IRBPs. Furthermore, allowing impeller speed to vary in magnetically suspended IRBPs may affect suspension control. A preferred pump uses a hydro dynamically suspended impeller and therefore suspension controls are not needed.
  • Calculation of Instantaneous Impeller Speed N(t) and rms of Impeller Speed Nrms(t)
  • Each pulse from the commutation controller represents ⅙th of a rotation of the impeller and is time stamped relative to a reference time base. Therefore the angular velocity ω of the impeller for each 60° of rotation is described by equation 1.
  • ω ( T ) = 2 Π 6 [ ( Tn + 1 ) - Tn ] equation 1
  • where Tn+1−Tn is the time difference between pulses (interrupts) in seconds. ω(t) is converted to speed N(t) in rpm by multiplying by 60/2II as-in equation 2
  • N ( t ) = 60 ω ( t ) 2 π equation 2
  • Rms speed is calculated in equation 3 from a moving window of samples of N(t), the sample rate dependent on impeller speed. Each instantaneous speed sample is time stamped at t1 to tn.
  • Nrms ( t ) = o n [ N ( t ) ] 2 n equation 3
  • Calculation of Instantaneous and Rms Electrical Input Power Pin(t).
  • Calculation of pump electrical power is a direct way to monitor the power consumption of the pump. Since the pump power and speed is modulated by the heart which is an asymmetrical modulation (due to the ejection fraction not being 50% rms) calculation of both instantaneous power and speed is implemented. Power is calculated using equation 4.

  • Pin(P)=Vm(iIm(t)  equation 4
  • Where Vm(t) and Im(t) are the “instantaneous” motor coil voltage and summed phase current respectively, sampled. A moving window of samples of Pin(t) is used to calculate Prms(t) using equation 5.
  • P rms ( t ) = o n [ Pin ( t ) ] 2 n equation 5
  • Second Embodiment
  • With reference to FIGS. 5 to 7 inclusive there will now be described a control system in accordance with a second preferred embodiment:
  • In relation to this second embodiment the control strategy is similar to that described with respect to the first embodiment but, in addition, includes as a further control input derived from non-invasively determined parameters the “pumping state” of pump 10. This feature provides a safety-override mechanism as illustrated in the flowchart of FIG. 7 thereby to ensure that the basic control strategy described with reference to the first embodiment is less likely to put the patient at risk. Initially in the description which follows invasively derived parameters are discussed showing how the various pumping states have been defined and come to be identified. A method of non-invasively deriving the same parameters and pumping state determinations is then described with both forms of derivation being summarized in table 1.
  • With reference to FIG. 4 experimental data suggests that there is a correlation between heart rate and accelerometer output where at least a single axis accelerometer is attached to a patient and used as a measure of physical activity of the patient. This observation is used for the control algorithm now to be described.
  • FIG. 5 is a block diagram of the control arrangement wherein, in addition to the input variables described with reference to example 1 there is a “physical motion” input which can be derived from an accelerometer associated with a patient. In the simplest form the accelerometer can be a single axis accelerometer. In alternative forms multiple axes of accelerometer sensing can be utilized.
  • Detection of Physiologically Significant Pumping States
  • Physiologically critical pumping state detection methods are used based on the non-invasive system observers pump speed and electrical input power. Activity level is detected using heart rate (detected from pump impeller instantaneous speed) and motion by using an accelerometer although other measuring devices may be used without departing from the scope of the present invention. These non-invasive observers are utilized as inputs to a control algorithm for a rotary blood pump to seek to ensure that pump output is better adapted to patient rest and exercise states.
  • Identifying Pumping States
  • Methods were developed to detect pumping states based on instantaneous measured pump power and speed. The methods developed allow impeller speed and pump input power to be freely modulated by ventricular contractions. This dynamic information is utilized as feedback to the control system. Data from in-vitro and in-vivo experiments shows that states TVC (total ventricular collapse) and PR (pump regurgitation) produce low flow through the pump. State TVC produces non-pulsatile low flow while state PR produces pulsatile low flow less than 1 L/min. States PVC (Partial Ventricular Collapse), AC (Aortic valve Closed) and VE (Ventricle Ejecting) produce normal pump flows greater than IL/min. States PVC and PR can be differentiated from state AC since flow pulsatility is more evident. State PVC can be differentiated from state VE since the dynamic flow symmetry is different from all other states. The dynamic nature of the flow is reflected by pump speed and power. Instantaneous measured pump speed is used to indicate flow dynamics.
  • Detecting of State TVC, Ventricle Totally Collapsed Occluding the Inlet Cannula.
  • Examining the in-vitro and in-vivo data it has been found that state TVC can be consistently detected by fall in pump flow to near 0 L/min accompanied by a reduction of flow pulsatility. It has been observed Flow waveform symmetry may not be relevant for detection of this state.
  • Detecting State PVA, Ventricle not Ejecting and Beginning to Collapse onto the Cannula
  • The state PVC is indicated by a variation in symmetry of the instantaneous speed waveform given a level of pulsatility. Given that normal flow rates can still be observed during this state and that flow pulsatility is large, the only parameter distinguishing this state from the VE state is the flow symmetry.
  • State AC Ventricle not Ejecting and Positive Pump Flow.
  • By analyzing the cardiac cycle with the pump it has been was found that there may be a portion of state AC where the aortic valve remains closed, whilst however the pump flow is still pulsatile. Assistance beyond this point causes pump flow pulsatility to reduce. At high perfusion demands, as in exercise, the failed ventricle may be supplemented to such an extent that the flow through the pump is pulse-less. Theoretically if no left ventricle contraction occurs then implantable rotary blood plump flow will be non pulsatile. Contraction of the left ventricle with the pump connected means that pump head is proportional to the difference between the aortic pressure and the left ventricular pressure (LVP). If the pump power is increased beyond the point that the left ventricle is doing no work (the aortic valve no longer opens) maximum LVP begins to decrease. This means that minimum instantaneous pump differential pressure will begin to rise relative to the RMS of the pump differential pressure over the cardiac cycle. If the ventricle is weakened through heart failure this will occur at relatively lower pump speeds and the mitral valve will still continue to open and LVP maximum will decrease towards zero with increasing speeds. During this interval the mitral valve will open and close. Steady flow occurs when there is no pulsatility in the speed signal and the mitral valve never closes. The target speed at which this occurs will increase with SVR or VR and cardiac contractility. Continuing to increase the pump power will cause the transition from pulsatile to non pulsatile flow. This means detection of the state VE and state AC can only be achieved dynamically by considering the maximum instantaneous speed Nmax(t) and the rms of instantaneous speed Nrms(t) for the nth and (n-l)th cardiac cycle. A significant change occurs only if there is a change in average pump speed set point, after load or pre load. A method of detecting the AC state without relying on transitions has been chosen which uses peak to peak flow rate given that pump flow is greater than 1 L/min.
  • Detecting State VE, Ventricle Ejecting with Positive Pump Flow
  • State VE may be identified non invasively by pump flow rate being larger than 1 L/min and peak to peak instantaneous voltage (flow) being greater than a threshold value and the flow symmetry being greater than that for the PVC state.
  • Detecting State PR: The Point at which Pump Flow Rate is Less than Zero
  • The PR state may be indicated when the pump flow falls below the lower flow limits Qmin which is set to be 1 L/min. This level of Qmin is set at 1 L/min although not “0 L/min” may be was considered a safe limit to be classed as retrograde flow.
  • Pumping State Detection Using Non-Invasive Pump Parameters
  • By analyzing pump parameters deriving from invasive-derived parameters it is postulated that flow, flow amplitude and waveform symmetry appear to be good indicators of pumping state using only non-invasively-derived pump parameters. These variables can be detected non-invasively using estimated pump flow (Qest), peak to peak instantaneous speed Npp(n) and symmetry Nsym(n). Table 1 shows the relationship of physiological parameters to non-invasive pump parameters for each of the physiologically identified pumping states which have been taken from in-vitro and in-vivo data sets (n=3).
  • TABLE 1
    A summary of physiological (invasive) and pump (non-invasive)
    parameters used as the criteria to identify pumping states.
    Identifying Parameter
    Non-invasive via pump
    Invasion (Physiological) (from speed and power)
    AoP Pulse Press. LVP max Qav QestRMS(t) Npp(n)
    State mmHg (mmHg) (mmHg) (L/min) (L/min) Qsym(n) (rpm)
    TVC <40 <10 <40 <1 <1 <30
    PVC 60-180 >10 60-180 <1 >1 <0.4 >30
    AC 60-180 <10 <AoP <1 >1 <30
    VE 60-180 >10 >AoP >1 >1 >0.4 >30
    PR 60-180 >10 >AoP >1 <1 >0.4 >30
  • Estimated pump flow Qest is derived from Nrms(t) and PWRrms(t). The RMS of instantaneous pump speed Nrms(t) and power PWRrmst) are derived from instantaneous speed N(t) and power PWR(t). The haemo-dynamic controller electronics measure the frequency of the speed signal, which is proportional to impeller speed. Using speed rather than power as an observer for dynamic changes is an advantage since it is a digital signal, substantially free from electrical noise which may contribute to error.
  • Detecting Low Flow
  • Equation 6 is used to model low and normal flow rate through the pump based on RMS impeller speed and electrical input power.

  • Q est αK+speed+Pwr+(Pwr)2+(Pwr)3  equation 6
  • A flow Index, QpIndex, shown in equation 7 is developed to distinguish between low flow rates and normal flow rates. by incorporating Qest. If QpIndex>50 this corresponds in this example to a flow rate greater than 1 L/min. A QpIndex<50 means that flow is less than 1 L/min or “low flow”

  • Q pIndex=50·Q est  equation 7
  • Both the TVC and the PR pumping states defined and discussed produce low pump flow rates. States PVC, AC and VE produce “normal” flow rates where the circulation is not compromised.
  • Detecting Pulsatile Flow
  • States TVC and AC produce near non pulsatile pump flow. The difference between these states is that state AC occurs when the circulation is supported and state TVC when it is not. These states can be differentiated by comparing QestIndex. States PVC, VE and PR produces pulsatile flow. States PVC and VE produce flow which supports the circulation whereas state PR compromises the circulation due to back flow through the pump. It has been shown that instantaneous speed amplitude is proportional to pump flow amplitude. The flow pulsatility index Qp.p Index (equation 9) is developed based on instantaneous speed amplitude Np-p (n) (equation 8) which is equal to the difference between the maximum and the minimum instantaneous impeller speed Nmax(n) and Nmin(n) for the nth cardiac cycle. The index outputs a value greater than 50 for pulsatile flow and less than 50 for non pulsatile flow.

  • N p-p(n)=N max(n)−N min(n)  equation 8
  • Q p - p Index = 50 · Q p - p min N p - p ( n ) equation 9
  • Detecting Variations in Flow Symmetry
  • The in-vitro and in-vivo data show that instantaneous speed reflects the inverse symmetry of pump flow whilst current reflects the same symmetry, although speed exhibits less electrical noise. Thus it is postulated that the symmetry of flow can be estimated by using the inverted symmetry of instantaneous speed.
  • States PVC and VE both produce flow rates which support the circulation and a degree of pulsatility. Differentiating between states can be achieved by considering the symmetry of the flow wave form which is reflected in instantaneous speed. The symmetry of flow rate is an inversion of the instantaneous speed signal. The flow symmetry index QsymIndex (equation 11) is developed by using the inverted speed waveform symmetry defined by equation 10 with the symmetry threshold QsymMAX set at 0. The index is set so that if the flow symmetry falls below 0.3 (speed symmetry rises above 0.7) its output is less than 50.
  • N sym = ( N nrms ( n ) - N min ( n ) N p - p ( n ) equation 10 Q sym Index = 50 Q sym max . N sym equation 11
  • Determining the Current Pumping State From Non-Invasive Indicators
  • The block diagram shown in FIG. 5 shows the module that combines the detection methods discussed above derived from instantaneous power and speed. The current state is determined by the logic table shown in FIG. 6 where flow, flow pulsatility and symmetry are used to decide the present pumping state.
  • Detection of Heart Rate Using Pump Speed
  • [While pulsatile flow is detected, the heart rate is calculated by using the array of speed samples. For the entire speed array N[t1-tn] of samples the frequency of speed is calculated by using the derivative of speed and detecting the time of the speed maxima and minima. The derivative of speed is defined in equation 12.
  • N ( t n ) t = N ( t n ) - N ( t n - 1 ) Δ t equation 12
  • HR is then calculated by time stamping the maxima and minima of the speed signal given by HRa and HRb in is equations 13 and 14. The average is then computed and used as HR using equation 15. Speed maxima are detected by dN(tn)/dt changing from a positive to a negative value. Speed minima are detected by dN(tn)/dt changing from a negative to a positive value. Tmax(n), tmax(n-1), tmin(n), tmin(n-1) are the time stamps for the maximum and minimum values of instantaneous speed.
  • HRa = 60 [ t max ( n ) - t max ( n - 1 ) ] equation 13 HRb = 60 [ t min ( n ) - t min ( n - 1 ) ] equation 14
  • Detection of Physical Motion
  • An accelerometer is mounted in the controller electronics and used to detect physical motion. The accelerometer output is amplified by a differential amplifier and integrated to provide a signal level indicating continuous physical motion.
  • A preferred embodiment of the present invention of the physiological demand responsive controller is suited for used with implantable third generation LVASs. Also, a further embodiment of the present invention is designed to cooperate with a Ventrassist™ left ventricle assist system (LVAS).
  • One of the preferred embodiments may automatically adjust the pumping speed of an implanted third generation blood pump to an optimal level for the varying physiological needs of the implanted patient. The preferred embodiment may achieve this by periodically iteratively changing the speed setpoint of the pump. When the control system detects increased physiological demand by the patient (e.g. by physical exertion) the controller will increase the pumping speed accordingly. The pumping state of the patient's heart and physiological demand of the patient will be computed by the control system. in real time as functions of the pump's motor power and speed setpoint of the pump. Additionally, the physiological demand of the patient may also be detected by the use of a three axis accelerometer.
  • This accelerometer may be able to detect the instantaneous motion of the patient. Preferably, this instantaneous motion may also be indicative of the relative motion of the patient. The output of the accelerometer may preferably be directed into a conditioning circuit to digitize and filter the output signal of said accelerometer. This signal will then be passed from the conditioning circuit to a computational module which derives a physiological demand state (e.g. resting, sleeping, exercising, or patient collapse) as a numerically represented version of the state (e.g. 1=resting; 2=sleeping etc). The numerically represented version of the physiological demand state may then be inputted into the control system for a pumping device or medical device. The pumping speed of the implantable blood pump may then be altered in respect of the predetermined range for physiological demand for a particular patient.
  • Preferably, the predetermined ranges of pumping speeds will be set by a specialist doctor at the time of implantation of the blood pump. Additionally, it may be preferable to allow doctors to amend the predetermined range as they see fit.
  • Preferably in an embodiment of the present invention the control system may include a specialized algorithm. This algorithm may include a mathematical model of ideal pumping speed of an implantable blood pump for suitable physiological conditions of the patient. This algorithm may receive input or data included within three broad areas of data. These areas of data may include pump power, instantaneous pump speed and physical motion. The algorithm within the controller system (see FIG. 9) may use these areas of data to predict certain patient data. This patient data may include blood flow rate, heart rate, flow profile, pulsatility and physiological demand. The algorithm will then output the preferred pump speed and the remainder of the controller system will use this information to set a speed setpoint for the blood pump.
  • Preferably, an embodiment of the present invention will be such that iterative changes will be able to be made in timely manner.
  • In a further embodiment of the present invention, a preferred physiological demand responsive controller system may be adapted for use with a radial off flow type centrifugal blood pump.
  • The above describes only some embodiments of the present invention and modifications, obvious to those skilled in the art, can be made thereto without departing from the scope and spirit of the present invention.
  • The system is particularly suited for use with pumps which exhibit a relatively flat HQ curve as described with reference to FIG. 8. In particular, but not exclusively, pumps of the radial off flow type as, for example, described in International Patent Application PCT/AU98/00725 can exhibit this relatively flat characteristic. The description of PCT/AU98/00725 is incorporated herein by cross-reference.

Claims (22)

1-30. (canceled)
31. A controller for use with a blood pump, comprising:
a pump controller configured for sending a pump speed signal to the pump for controlling the pump speed;
a physiological controller for detecting a user's activity level based on a signal received from an accelerometer; and
the controller being further configured for detecting a pumping state and the user's heart rate based on signals received from the pump;
wherein the pump speed signal is derived from the detected pumping state and the user's heart rate and activity level.
32. The controller of claim 31, wherein the accelerometer is mounted in the controller.
33. The controller of claim 31, wherein the controller is configured for deriving the user's heart rate based on an instantaneous impeller speed of the pump.
34. The controller of claim 31, wherein the pump speed signal is derived from the detected heart rate and activity level unless the detected pumping state indicates that a Total Ventricular Collapse (TVC) or a Partial Ventricular Collapse (PVC) pumping state exists.
35. The controller of claim 31, wherein the controller is configured for detecting the pumping state based on input power to the pump and pump speed.
36. The controller of claim 35, wherein the controller is configured for detecting at least one of a total ventricular collapse, pump regurgitation and partial ventricular collapse pumping states.
37. The controller of claim 35, wherein the controller is configured for detecting a flow rate of the pump based on input power to the pump.
38. A controller for use with a blood pump, comprising:
a pump controller capable of controlling pump speed;
an accelerometer mounted in the controller; and
the controller further including a physiological controller adapted to detect physical motion of the user based on signals received from the accelerometer and generate a signal for the pump controller to adjust pump speed according to the detected physical motion;
wherein the signal for the pump controller is based on signals received from the accelerometer and integrated over time to detect a continuous physical motion of the user.
39. The apparatus of claim 38, wherein the detected physical motion is based on both accelerometer signals and a detected heart rate of the user.
40. The apparatus of claim 38, wherein the controller is configured for selecting a pumping speed from a predetermined range of pumping speeds according to the detected physical motion.
41. The apparatus of claim 40, wherein the controller further includes a conditioning circuit for identifying a physiological demand state representative of the physiological state of the user based on the signals received from the accelerometer, wherein the pumping speed is selected according to the identified physiological demand state of the user.
42. The apparatus of claim 38, wherein the signal is generated from the detected physical motion, pump power and instantaneous pump speed.
43. The apparatus of claim 42, wherein the controller includes an algorithm for predicting blood flow rate, heart rate, flow profile, pulsatility and physiological demand based on the detected physical motion, pump power and instantaneous pump speed, and wherein the algorithm produces a preferred pump speed which is used to generate the signal for the pump controller.
44. A controller for use with a blood pump, comprising:
a pump controller capable of controlling pump speed; and
the controller being configured for generating a speed control signal for the pump controller based on a detected physiological state of the user and pumping state of the pump;
wherein the physiological state is detected from data received from a non-invasive sensor; and
wherein the pumping state is detected from signals received from the pump.
45. The controller of claim 44, wherein the controller includes an alarm which is activated when the detected pumping state indicates that a physiologically critical pumping state exists.
46. The controller of claim 45, wherein the physiologically critical pumping state is a Total Ventricular Collapse (TVC) or a Partial Ventricular Collapse (PVC).
47. The controller of claim 44, wherein the non-invasive sensor is an accelerometer.
48. The controller of claim 44, wherein the pumping state is detected from a pump impeller speed signal and an input power to the pump.
49. The controller of claim 48, wherein the pump impeller speed signal and input power to the pump is used by the controller in a feedback loop to reduce pump speed when a physiologically critical pumping state is detected.
50. The controller of claim 44, wherein the physiological state is detected from data received from an accelerometer and a detected heart rate.
51. The controller of claim 44, wherein the detected pumping state is one of a Total Ventricular Collapse (TVC), Partial Ventricular Collapse (PVC), Ventricle Ejecting (VE), Aortic Valve Closed (AC) or Pump Regurgitation (PR).
US13/172,748 2002-09-30 2011-06-29 Physiological Demand Responsive Control System Abandoned US20120004497A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/172,748 US20120004497A1 (en) 2002-09-30 2011-06-29 Physiological Demand Responsive Control System

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2002951685A AU2002951685A0 (en) 2002-09-30 2002-09-30 Physiological demand responsive control system
AU2002951685 2002-09-30
PCT/AU2003/001281 WO2004028593A1 (en) 2002-09-30 2003-09-30 Physiological demand responsive control system
US10/529,657 US7988728B2 (en) 2002-09-30 2003-09-30 Physiological demand responsive control system
US13/172,748 US20120004497A1 (en) 2002-09-30 2011-06-29 Physiological Demand Responsive Control System

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/AU2003/001281 Division WO2004028593A1 (en) 2002-09-30 2003-09-30 Physiological demand responsive control system
US11/529,657 Division US7938997B2 (en) 2002-07-05 2006-09-27 Preparation of bulk superhard B-C-N nanocomposite compact

Publications (1)

Publication Number Publication Date
US20120004497A1 true US20120004497A1 (en) 2012-01-05

Family

ID=28047438

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/529,657 Active 2026-09-24 US7988728B2 (en) 2002-09-30 2003-09-30 Physiological demand responsive control system
US13/172,748 Abandoned US20120004497A1 (en) 2002-09-30 2011-06-29 Physiological Demand Responsive Control System

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/529,657 Active 2026-09-24 US7988728B2 (en) 2002-09-30 2003-09-30 Physiological demand responsive control system

Country Status (6)

Country Link
US (2) US7988728B2 (en)
EP (1) EP1549363A4 (en)
JP (1) JP2006500982A (en)
AU (1) AU2002951685A0 (en)
CA (1) CA2500554A1 (en)
WO (1) WO2004028593A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9144638B2 (en) 2013-03-14 2015-09-29 Thoratec Corporation Blood pump rotor bearings
EP3787706A4 (en) * 2018-05-03 2021-06-30 Northern Development AS Implantable device and delivery method
US20210268262A1 (en) * 2018-06-11 2021-09-02 Universität Zürich Blood pump for mechanical circulatory support for fontan patients
WO2021242659A1 (en) * 2020-05-26 2021-12-02 Medtronic, Inc. Body position and activity based flow control for ventricular assist device (vad) with fully implantable controller

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6889082B2 (en) 1997-10-09 2005-05-03 Orqis Medical Corporation Implantable heart assist system and method of applying same
AUPP995999A0 (en) 1999-04-23 1999-05-20 University Of Technology, Sydney Non-contact estimation and control system
AUPR514201A0 (en) 2001-05-21 2001-06-14 Ventrassist Pty Ltd Staged implantation of ventricular assist devices
AU2003903726A0 (en) * 2003-07-18 2003-07-31 Ventracor Limited A device for detecting heart pumping state
EP1670524A4 (en) 2003-10-09 2012-12-26 Thoratec Corp Impeller
US20060083642A1 (en) 2004-10-18 2006-04-20 Cook Martin C Rotor stability of a rotary pump
US8202217B2 (en) * 2004-12-20 2012-06-19 Ip Venture, Inc. Healthcare base
US10130801B1 (en) * 2005-02-07 2018-11-20 Ipventure, Inc. Electronic transdermal chemical delivery
US20070142923A1 (en) 2005-11-04 2007-06-21 Ayre Peter J Control systems for rotary blood pumps
US8162634B2 (en) 2005-12-01 2012-04-24 Michigan Critical Care Consultants, Inc. Pulsatile rotary ventricular pump
US8112293B2 (en) * 2006-03-24 2012-02-07 Ipventure, Inc Medical monitoring system
EP1847281A1 (en) 2006-04-20 2007-10-24 Ventrassist Pty Ltd System and method of controlling a rotary blood pump
US7850594B2 (en) 2006-05-09 2010-12-14 Thoratec Corporation Pulsatile control system for a rotary blood pump
US7963905B2 (en) 2006-10-11 2011-06-21 Thoratec Corporation Control system for a blood pump
US20080133006A1 (en) 2006-10-27 2008-06-05 Ventrassist Pty Ltd Blood Pump With An Ultrasonic Transducer
JP5266464B2 (en) 2007-05-10 2013-08-21 ライニッシュ−ヴェストフェリッシェ・テクニッシェ・ホッホシューレ・アーヘン Cardiac function change evaluation device
US10178965B2 (en) * 2007-06-22 2019-01-15 Ipventure, Inc. Activity monitoring system for pregnant women
US9011334B2 (en) * 2007-09-27 2015-04-21 Baxter International Inc. Access disconnect detection
EP2210203A1 (en) * 2007-10-24 2010-07-28 Medtronic, Inc. Remotely-requested integrity diagnostics
WO2010017309A1 (en) 2008-08-05 2010-02-11 Michigan Critical Care Consultants, Inc. Apparatus and method for monitoring and controlling extracorporeal blood flow relative to patient fluid status
KR101686887B1 (en) 2008-09-10 2016-12-15 하트웨어, 인코포레이티드 Tet device for implanted medical device
WO2010093946A1 (en) * 2009-02-12 2010-08-19 Mc3, Inc. Modular fluid pump with cartridge
US8562507B2 (en) 2009-02-27 2013-10-22 Thoratec Corporation Prevention of aortic valve fusion
US8449444B2 (en) 2009-02-27 2013-05-28 Thoratec Corporation Blood flow meter
WO2010101107A1 (en) 2009-03-06 2010-09-10 Ntn株式会社 Centrifugal pump device
EP2525870B1 (en) 2010-01-19 2019-03-13 Heartware, Inc. Physiologically responsive vad
WO2011163421A1 (en) 2010-06-22 2011-12-29 Thoratec Corporation Fluid delivery system and method for monitoring fluid delivery system
WO2011163360A1 (en) 2010-06-22 2011-12-29 Thoratec Corporation Apparatus and method for modifying pressure-flow characteristics of a pump
JP5577506B2 (en) 2010-09-14 2014-08-27 ソーラテック コーポレイション Centrifugal pump device
US9757502B2 (en) 2010-09-24 2017-09-12 Tci Llc Control of circulatory assist systems
EP3117845B1 (en) 2010-09-24 2018-10-31 Tc1 Llc Generating artificial pulse
TW201221161A (en) 2010-10-13 2012-06-01 Thoratec Corp Pumping blood
EP2693609B1 (en) 2011-03-28 2017-05-03 Thoratec Corporation Rotation and drive device and centrifugal pump device using same
WO2013003370A2 (en) * 2011-06-27 2013-01-03 Heartware, Inc. Flow estimation in a blood pump
WO2013056131A1 (en) 2011-10-13 2013-04-18 Reichenbach Steven H Pump and method for mixed flow blood pumping
EP3159023B1 (en) 2012-03-05 2017-11-29 Tc1 Llc Method of calibrating implantable medical pumps
US11621583B2 (en) 2012-05-21 2023-04-04 University Of Washington Distributed control adaptive wireless power transfer system
US8827889B2 (en) 2012-05-21 2014-09-09 University Of Washington Through Its Center For Commercialization Method and system for powering implantable devices
WO2014042925A2 (en) 2012-09-13 2014-03-20 Circulite, Inc. Blood flow system with variable speed control
US9371826B2 (en) 2013-01-24 2016-06-21 Thoratec Corporation Impeller position compensation using field oriented control
US9556873B2 (en) 2013-02-27 2017-01-31 Tc1 Llc Startup sequence for centrifugal pump with levitated impeller
US9789236B2 (en) 2013-03-14 2017-10-17 Yale University Implantable heart pump controller
US9919088B2 (en) 2013-03-14 2018-03-20 Yale University Implantable heart pump controller
US10052420B2 (en) 2013-04-30 2018-08-21 Tc1 Llc Heart beat identification and pump speed synchronization
GB201311494D0 (en) 2013-06-27 2013-08-14 Univ Oslo Hf Monitoring of a cardiac assist device
KR20160039242A (en) 2013-08-02 2016-04-08 서클라이트, 인크. Implantable system with secure remote control
EP2865397A1 (en) * 2013-10-22 2015-04-29 Berlin Heart GmbH Method for operating a pump device and pump device
SE537628C2 (en) 2013-11-08 2015-08-18 Bonvisi Ab Device for irrigation and insufflation with blood pressure dependent pressure control
US9623161B2 (en) * 2014-08-26 2017-04-18 Tc1 Llc Blood pump and method of suction detection
JP2017529954A (en) 2014-10-01 2017-10-12 ハートウェア、インコーポレイテッド Backup control system with update
WO2016086137A1 (en) 2014-11-26 2016-06-02 Thoratec Corporation Pump and method for mixed flow blood pumping
US9717832B2 (en) 2015-01-06 2017-08-01 HeartWave, Inc. Axial flow rotor with downstream bearing wash flow
EP3256183A4 (en) 2015-02-11 2018-09-19 Tc1 Llc Heart beat identification and pump speed synchronization
US10371152B2 (en) 2015-02-12 2019-08-06 Tc1 Llc Alternating pump gaps
US10166318B2 (en) 2015-02-12 2019-01-01 Tc1 Llc System and method for controlling the position of a levitated rotor
US10245361B2 (en) 2015-02-13 2019-04-02 Tc1 Llc Impeller suspension mechanism for heart pump
EP3352809B1 (en) 2015-09-25 2019-08-07 Heartware, Inc. Blood pump for ischemia detection and treatment
US10117983B2 (en) 2015-11-16 2018-11-06 Tc1 Llc Pressure/flow characteristic modification of a centrifugal pump in a ventricular assist device
US9968720B2 (en) 2016-04-11 2018-05-15 CorWave SA Implantable pump system having an undulating membrane
US10166319B2 (en) 2016-04-11 2019-01-01 CorWave SA Implantable pump system having a coaxial ventricular cannula
US10857273B2 (en) 2016-07-21 2020-12-08 Tc1 Llc Rotary seal for cantilevered rotor pump and methods for axial flow blood pumping
US10660998B2 (en) 2016-08-12 2020-05-26 Tci Llc Devices and methods for monitoring bearing and seal performance
DE102017000940A1 (en) * 2017-02-02 2018-08-02 Xenios Ag Arrangement with a blood pump, a control unit and a device for transmitting the measured values
US11065436B2 (en) 2017-03-29 2021-07-20 Tc1 Llc Communication methods and architecture for heart treatment systems
US10835654B2 (en) 2017-03-29 2020-11-17 Tc1 Llc Pressure sensing ventricular assist devices and methods of use
WO2018183565A1 (en) 2017-03-29 2018-10-04 Harjes Daniel I Adjusting protocol based on irregular heart rhythm
CN110636873B (en) 2017-03-31 2022-06-14 科瓦韦公司 Implantable pump system with rectangular membrane
EP4233989A3 (en) 2017-06-07 2023-10-11 Shifamed Holdings, LLC Intravascular fluid movement devices, systems, and methods of use
CN111107891A (en) 2017-07-17 2020-05-05 利弗梅特里克(医疗)股份公司 Method and system for ventricular assist device adjustment using a wearable device
FR3073578B1 (en) 2017-11-10 2019-12-13 Corwave FLUID CIRCULATOR WITH RINGING MEMBRANE
US11511103B2 (en) 2017-11-13 2022-11-29 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
US10188779B1 (en) 2017-11-29 2019-01-29 CorWave SA Implantable pump system having an undulating membrane with improved hydraulic performance
JP7410034B2 (en) 2018-02-01 2024-01-09 シファメド・ホールディングス・エルエルシー Intravascular blood pump and methods of use and manufacture
EP3765113B1 (en) 2018-03-15 2024-10-30 Tc1 Llc Systems for preventing right heart failure
US11167123B2 (en) 2018-03-19 2021-11-09 Tc1 Llc Coordinated ventricular assist and cardiac rhythm management devices and methods
CN108671296B (en) * 2018-05-25 2021-04-16 中国计量大学 Multi-level multi-target left ventricle auxiliary blood pump physiological control system
US11241570B2 (en) 2018-07-17 2022-02-08 Tc1 Llc Systems and methods for inertial sensing for VAD diagnostics and closed loop control
JP2022540616A (en) 2019-07-12 2022-09-16 シファメド・ホールディングス・エルエルシー Intravascular blood pump and methods of manufacture and use
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
EP4034184A4 (en) 2019-09-25 2023-10-18 Shifamed Holdings, LLC Catheter blood pumps and collapsible blood conduits
EP4034192A4 (en) 2019-09-25 2023-11-29 Shifamed Holdings, LLC Intravascular blood pump systems and methods of use and control thereof
EP4034221A4 (en) 2019-09-25 2023-10-11 Shifamed Holdings, LLC Catheter blood pumps and collapsible pump housings
WO2021176423A1 (en) 2020-03-06 2021-09-10 CorWave SA Implantable blood pumps comprising a linear bearing
US12017059B2 (en) 2022-11-15 2024-06-25 CorWave SA Implantable heart pump systems including an improved apical connector and/or graft connector
CN116803447B (en) * 2023-08-04 2024-11-01 萱闱(北京)生物科技有限公司 Model construction method, parameter configuration method and related device
CN116889684B (en) * 2023-08-04 2024-01-26 萱闱(北京)生物科技有限公司 Parameter configuration method and system of blood supply driving device and related device

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010037067A1 (en) * 2000-05-09 2001-11-01 Patrick Tchou System and method for monitoring progression of cardiac disease state using physiologic sensors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5267940A (en) * 1989-11-29 1993-12-07 The Administrators Of The Tulane Educational Fund Cardiovascular flow enhancer and method of operation
US5289821A (en) 1993-06-30 1994-03-01 Swartz William M Method of ultrasonic Doppler monitoring of blood flow in a blood vessel
GB9405002D0 (en) * 1994-03-15 1994-04-27 Univ Manitoba Apparatus and method of use for pulsatile blood flow with return of in vivo variability of the pulse waveform
US6071093A (en) 1996-10-18 2000-06-06 Abiomed, Inc. Bearingless blood pump and electronic drive system
US5888242A (en) * 1996-11-01 1999-03-30 Nimbus, Inc. Speed control system for implanted blood pumps
US5807234A (en) * 1997-06-27 1998-09-15 Pacesetter, Inc. Myostimulator control using metabolic demand and muscle performance
US6068588A (en) * 1999-01-07 2000-05-30 International Business Machines Corporation Counterbalanced pump
US7138776B1 (en) 1999-07-08 2006-11-21 Heartware, Inc. Method and apparatus for controlling brushless DC motors in implantable medical devices
US6277078B1 (en) 1999-11-19 2001-08-21 Remon Medical Technologies, Ltd. System and method for monitoring a parameter associated with the performance of a heart
JP2001207988A (en) 2000-01-26 2001-08-03 Nipro Corp Magnetic driving type axial flow pump
US7645225B2 (en) 2000-03-27 2010-01-12 Alexander Medvedev Chronic performance control system for rotodynamic blood pumps
US20020183628A1 (en) 2001-06-05 2002-12-05 Sanford Reich Pressure sensing endograft
AU2002331563A1 (en) 2001-08-16 2003-03-03 Apex Medical, Inc. Physiological heart pump control
US6991595B2 (en) 2002-04-19 2006-01-31 Thoratec Corporation Adaptive speed control for blood pump
US7494459B2 (en) * 2003-06-26 2009-02-24 Biophan Technologies, Inc. Sensor-equipped and algorithm-controlled direct mechanical ventricular assist device

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010037067A1 (en) * 2000-05-09 2001-11-01 Patrick Tchou System and method for monitoring progression of cardiac disease state using physiologic sensors

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9144638B2 (en) 2013-03-14 2015-09-29 Thoratec Corporation Blood pump rotor bearings
US9759222B2 (en) 2013-03-14 2017-09-12 Tc1 Llc Blood pump rotor bearings
EP3787706A4 (en) * 2018-05-03 2021-06-30 Northern Development AS Implantable device and delivery method
US20210268262A1 (en) * 2018-06-11 2021-09-02 Universität Zürich Blood pump for mechanical circulatory support for fontan patients
US12109404B2 (en) * 2018-06-11 2024-10-08 Universität Zürich Blood pump for mechanical circulatory support for Fontan patients
WO2021242659A1 (en) * 2020-05-26 2021-12-02 Medtronic, Inc. Body position and activity based flow control for ventricular assist device (vad) with fully implantable controller
US20210370044A1 (en) * 2020-05-26 2021-12-02 Medtronic, Inc. Body position and activity based flow control for ventricular assist device (vad) with fully implantable controller
US11931561B2 (en) * 2020-05-26 2024-03-19 Medtronic, Inc. Body position and activity based flow control for ventricular assist device (VAD) with fully implantable controller

Also Published As

Publication number Publication date
US7988728B2 (en) 2011-08-02
EP1549363A4 (en) 2012-02-01
US20080183287A1 (en) 2008-07-31
AU2002951685A0 (en) 2002-10-17
JP2006500982A (en) 2006-01-12
EP1549363A1 (en) 2005-07-06
CA2500554A1 (en) 2004-04-08
WO2004028593A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
US7988728B2 (en) Physiological demand responsive control system
US12083330B2 (en) Prevention of aortic valve fusion
US10688232B2 (en) Pump preload index/indicator
JP5214836B2 (en) Long-term performance control system for turbo blood pump
US20200246525A1 (en) Blood pump
US8715151B2 (en) Blood flow meter
US6066086A (en) Speed control system for implanted blood pumps
EP1565231B1 (en) Rotary blood pump diagnostics and cardiac output controller
US20140142367A1 (en) Control systems for rotary blood pumps
EP2517740A2 (en) Blood pump system with controlled weaning
US20100222635A1 (en) Maximizing blood pump flow while avoiding left ventricle collapse
AU2003265729B2 (en) Physiological demand responsive control system
AU2006235839B2 (en) Improvements to Control Systems for Rotary Blood Pumps

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION